Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

SCREENING FOR UNDERSTANDING OF RESEARCH IN THE INPATIENT PSYCHIATRY SETTING JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS Hickman, N. J., Prochaska, J. J., Dunn, L. B. 2011; 6 (3): 65-72

Abstract

People with mental illness constitute a substantial proportion of smokers and an important population for smoking cessation research. Obtaining informed consent in this population is a critical ethical endeavor. We examined performance on a three-item instrument (3Q) designed to screen for understanding of several key elements of research: study purpose, risks, and benefits. Patients were clinically diagnosed with primary unipolar depression (n = 40), a primary psychotic disorder (n = 32), both mood and psychotic disorders (n = 17), and primary bipolar disorder (n = 14). Among an ethnically diverse sample of 124 psychiatric inpatients approached for a smoking cessation trial, 107 (86%) performed adequately on the 3Q (i.e., obtained a score of at least 3 out of a possible 6). Patients were better able to identify the study risks and benefits than to describe the study purpose. The 3Q appears to be a useful tool for researchers working with vulnerable psychiatric patients.

View details for DOI 10.1525/jer.2011.6.3.65

View details for Web of Science ID 000295878900008

View details for PubMedID 21931239

View details for PubMedCentralID PMC3357117